Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Aleris in connection with the acquisition of Art Clinic AB
Mandate

Vinge advises Aleris in connection with the acquisition of Art Clinic AB

May 03, 2022 M&A

Vinge advises Aleris Sjukvård AB in connection with the acquisition of Art Clinic AB. Art Clinic AB operates four specialized clinics with five sub-practices in six regions in Sweden.

Aleris is one of Scandinavia’s leading healthcare provider with two million patient appointments per year and operates specialized care at over 130 locations in Sweden, Norway and Denmark. Aleris strengthens through the transaction its specialized healthcare within orthopedics, back surgery as well as aesthetic and reconstructive plastic surgery in Sweden.

Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

Vinge’s team consisted of Christina Kokko, Samra Baytar, Olivia Belding and Elias Bohlin (M&A), Johan Wahlbom (Competition), Christoffer Nordin, Sam Fakhraie Ardekani and Max Hetta (Agreements), Emil Lindwall (Employment), Nour Makie (Banking and Finance), Karolina Fuhrman (IT/GDPR), Frida Ställborn (Real Estate) and Jessica Henning (VDR specialist).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025